ClarificationApr 30, 2026, 04:09 PM
ENVB Corrects Reverse Stock Split Ratio for AGM Proxy
AI Summary
Enveric Biosciences, Inc. filed additional proxy materials to correct a typographical error in its definitive proxy statement for the 2026 Annual Meeting of Stockholders. The error concerned the proposed reverse stock split ratio, which was incorrectly stated as 1-for-5 to 1-for-50. The correct range for the discretionary reverse stock split is 1-for-5 to 1-for-15. The Annual Meeting is scheduled for May 28, 2026, and other proposals, including director elections and an authorized stock increase, remain unchanged.
Key Highlights
- Corrected reverse stock split ratio range from 1-for-5 to 1-for-50 to 1-for-5 to 1-for-15.
- Annual Meeting of Stockholders scheduled for May 28, 2026, at 10:00 a.m. Eastern Time.
- Proposals include electing six directors and a non-binding advisory vote on executive compensation.
- Shareholders to vote on increasing authorized common stock from 100,000,000 to 5,000,000,000 shares.
- Ratification of CBIZ CPAs P.C. as independent auditor for fiscal year ending December 31, 2026.
- No changes to the Annual Meeting date, time, location, or any other proposals.